James Galloway
James Galloway
Adresse e-mail validée de kcl.ac.uk
Titre
Citée par
Citée par
Année
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
WG Dixon, KL Hyrich, KD Watson, M Lunt, J Galloway, A Ustianowski, ...
Annals of the rheumatic diseases 69 (3), 522-528, 2010
7092010
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results …
JB Galloway, KL Hyrich, LK Mercer, WG Dixon, B Fu, AP Ustianowski, ...
Rheumatology 50 (1), 124-131, 2011
6342011
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
JB Galloway, KL Hyrich, LK Mercer, WG Dixon, AP Ustianowski, M Helbert, ...
Annals of the rheumatic diseases 70 (10), 1810-1814, 2011
1832011
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology …
JB Galloway, LK Mercer, A Moseley, WG Dixon, AP Ustianowski, ...
Annals of the rheumatic diseases 72 (2), 229-234, 2013
1612013
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for …
LK Mercer, AC Green, JB Galloway, R Davies, M Lunt, WG Dixon, ...
Annals of the rheumatic diseases 71 (6), 869-874, 2012
1232012
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
LK Mercer, R Davies, JB Galloway, A Low, M Lunt, WG Dixon, KD Watson, ...
Rheumatology 52 (1), 91-98, 2013
1152013
Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
AI Rutherford, S Subesinghe, KL Hyrich, JB Galloway
Annals of the rheumatic diseases 77 (6), 905-910, 2018
962018
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis
K Bechman, S Subesinghe, S Norton, F Atzeni, M Galli, AP Cope, ...
Rheumatology 58 (10), 1755-1766, 2019
792019
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
LK Mercer, JB Galloway, M Lunt, R Davies, ALS Low, WG Dixon, ...
Annals of the rheumatic diseases 76 (3), 497-503, 2017
732017
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
J Ledingham, N Gullick, K Irving, R Gorodkin, M Aris, J Burke, P Gordon, ...
Rheumatology 56 (6), 865-868, 2017
712017
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti‑TNF therapy: results from the British Society for Rheumatology Biologics Register
R Davies, JB Galloway, KD Watson, M Lunt, DPM Symmons, KL Hyrich
Annals of the rheumatic diseases 70 (10), 1831-1834, 2011
652011
Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
AI Rutherford, E Patarata, S Subesinghe, KL Hyrich, JB Galloway
Rheumatology 57 (6), 997-1001, 2018
602018
British Society for Rheumatology Biologics Register,“Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent …
JB Galloway, KL Hyrich, LK Mercer, WG Dixon, B Fu, AP Ustianowski, ...
Arthritis and Rheumatism, 2007
582007
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study
JB Galloway, S Norton, RD Barker, A Brookes, I Carey, BD Clarke, R Jina, ...
Journal of Infection 81 (2), 282-288, 2020
552020
The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register
F Matcham, R Davies, M Hotopf, KL Hyrich, S Norton, S Steer, J Galloway
Rheumatology 57 (5), 835-843, 2018
502018
Apparatus and method for enriching data records in a telecommunications network
A Bruce, R Beattie, C Kane, J Galloway
US Patent 8,913,595, 2014
482014
A systematic review and metaanalysis of antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis
S Subesinghe, K Bechman, AI Rutherford, D Goldblatt, JB Galloway
The Journal of rheumatology 45 (6), 733-744, 2018
472018
The evidence base for psychological interventions for rheumatoid arthritis: a systematic review of reviews
L Prothero, E Barley, J Galloway, S Georgopoulou, J Sturt
International journal of nursing studies 82, 20-29, 2018
472018
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise
T Bharucha, A Rutherford, S Skeoch, A Alavi, M Brown, J Galloway, ...
Clinical radiology 72 (9), 764-771, 2017
372017
Anti-TNF therapy in women with rheumatoid arthritis with a history of carcinoma in situ of the cervix
LK Mercer, ASL Low, JB Galloway, KD Watson, M Lunt, DPM Symmons, ...
Annals of the rheumatic diseases 72 (1), 143-144, 2013
342013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20